Home > Healthcare > Analytical Instruments > Molecular Analysis > Next Generation Sequencing Market
Next Generation Sequencing Market Share
- Report ID: GMI3247
- Published Date: Apr 2023
- Report Format: PDF
Next Generation Sequencing Market Share
- 10X Genomics
- BGI
- Agilent Technologies Inc
- Bio-Rad Laboratories
- GenapSys Inc
- F Hoffmann-La Roche
- Illumina Inc
- Oxford Nanopore Technologies
- NanoString Technologies
- Pacific Biosciences of California, Inc
- Qiagen
- PerkinElmer Inc
- Thermo Fisher Scientific
are some top participants profiled in the market.
Frequently Asked Questions (FAQ) :
Global market for next generation sequencing was valued at USD 8 billion in 2022 and is primed to progress at over 19% CAGR between 2023 and 2032 propelled by rapid advancements in next-generation sequencing in developed nations.
The exome sequencing segment is poised to be worth more than USD 20 billion in revenue by the end of 2032 as a result of its benefits including the complete coverage of coding regions and the capability to detect changes across a wide range of applications.
The academic institutes & research centers segment is anticipated to reach a valuation of USD 12 billion by 2032 owing to extensive experiments carried out in laboratories to create breakthrough next-generation sequencing treatments.
North America next generation sequencing (NGS) market is slated to reach over USD 21 billion in revenue by 2032 driven by rising incidences of genetic and cancer disorders in the region.
Next Generation Sequencing Market Scope
×
Get a free sample of
Next Generation Sequencing Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below